Increased infiltrated macrophages in benign prostatic hyperplasia (BPH): Role of stromal androgen receptor in macrophage-induced prostate stromal cell proliferation

Journal of Biological Chemistry

Volumn 287, Issue 22, 2012, Pages 18376-18385

  Wang, Xiaohai ^a,b   Lin, Wen Jye ^a   Izumi, Kouji ^a   Jiang, Qi ^a   Lai, Kuo Pao ^a   Xu, Defeng ^a   Fang, Lei Ya ^a   Lu, Tianjing ^a   Li, Lei ^a   Xia, Shujie ^b   Chang, Chawnshang ^a,c  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b SHANGHAI JIAO TONG UNIVERSITY   (China)

^c CHINA MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTORS; BENIGN PROSTATIC HYPERPLASIA; COCULTURE; EXPRESSION LEVELS; SIGNALING PATHWAYS; STROMAL CELLS; UNDERLYING MECHANISM;

CELL CULTURE; CELL PROLIFERATION; DEGRADATION; MAMMALS; TISSUE; UROLOGY;

MACROPHAGES;

5 HYDROXY 1,7 BIS(3,4 DIMETHOXYPHENYL) 1,4,6 HEPTATRIEN 3 ONE; ANDROGEN RECEPTOR; ANDROGEN RECEPTOR ANTAGONIST; ASC J 9; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA ANTIBODY; NEUTRALIZING ANTIBODY; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL GROWTH; CELL INFILTRATION; CELL PROLIFERATION; COCULTURE; CONTROLLED STUDY; DRUG TARGETING; FEMALE; HUMAN; HUMAN TISSUE; MACROPHAGE; MACROPHAGE MIGRATION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROSTATE HYPERTROPHY; PROTEIN EXPRESSION; PROTEIN FUNCTION; STROMA CELL;

ANIMALS; BASE SEQUENCE; BLOTTING, WESTERN; DNA PRIMERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; IMMUNOHISTOCHEMISTRY; MACROPHAGES; MALE; MICE; PROSTATE; PROSTATIC HYPERPLASIA; RECEPTORS, ANDROGEN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STROMAL CELLS;

EID: 84861561279     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M112.355164     Document Type: Article

References (48)

1. Kramer, G., Mitteregger, D., and Marberger, M. (2007) Is benign prostatic hyperplasia (BPH) an immune inflammatory disease? Eur. Urol. 51, 1202-1216 (Pubitemid 46436310)
2. Nakhla, A. M., Khan, M. S., Romas, N. P., and Rosner, W. (1994) Estradiol causes the rapid accumulation of cAMP in human prostate. Proc. Natl. Acad. Sci. U.S.A. 91, 5402-5405 (Pubitemid 24174335)
3. Roberts, R. O., Bergstralh, E. J., Farmer, S. A., Jacobson, D. J., Hebbring, S. J., Cunningham, J. M., Thibodeau, S. N., Lieber, M. M., and Jacobsen, S. J. (2006) Polymorphisms in genes involved in sex hormone metabolism may increase risk of benign prostatic hyperplasia. Prostate 66, 392-404
4. Sciarra, F., and Toscano, V. (2000) Role of estrogens in human benign prostatic hyperplasia. Arch. Androl. 44, 213-220 (Pubitemid 30347104)
5. Wilson, J. D., and Griffin, J. E. (1980) The use and misuse of androgens. Metab. Clin. Exp. 29, 1278-1295 (Pubitemid 11154649)
6. Aydin, A., Arsova-Sarafinovska, Z., Sayal, A., Eken, A., Erdem, O., Erten, K., Ozgök, Y., and Dimovski, A. (2006) Oxidative stress and antioxidant status in nonmetastatic prostate cancer and benign prostatic hyperplasia. Clin. Biochem. 39, 176-179 (Pubitemid 43255508)
7. Kasturi, S., Russell, S., and McVary, K. T. (2006) Metabolic syndrome and lower urinary tract symptoms secondary to benign prostatic hyperplasia. Curr. Urol. Rep. 7, 288-292 (Pubitemid 44623991)
8. Ozden, C., Ozdal, O. L., Urgancioglu, G., Koyuncu, H., Gokkaya, S., and Memis, A. (2007) The correlation between metabolic syndrome and prostatic growth in patients with benign prostatic hyperplasia. Eur. Urol. 51, 199-203; discussion 204-196
9. Kramer, G., and Marberger, M. (2006) Could inflammation be a key component in the progression of benign prostatic hyperplasia? Curr. Opin. Urol. 16, 25-29 (Pubitemid 43041217)
10. Yi, F. X., Wei, Q., Li, H., Li, X., Shi, M., Dong, Q., and Yang, Y. R. (2006) Risk factors for prostatic inflammation extent and infection in benign prostatic hyperplasia. Asian J. Androl. 8, 621-627 (Pubitemid 44263437)
11. McVary, K. T., Rademaker, A., Lloyd, G. L., and Gann, P. (2005) Autonomic nervous system overactivity in men with lower urinary tract symptoms secondary to benign prostatic hyperplasia. J. Urol. 174, 1327-1433
12. Yun, A. J., and Doux, J. D. (2006) Opening the floodgates. Benign prostatic hyperplasia may represent another disease in the compendium of ailments caused by the global sympathetic bias that emerges with aging. Med. Hypotheses 67, 392-394
13. Claus, S., Wrenger, M., Senge, T., and Schulze, H. (1993) Immunohistochemical determination of age related proliferation rates in normal and benign hyperplastic human prostates. Urol. Res. 21, 305-308 (Pubitemid 23305744)
14. Kramer, G., Steiner, G. E., Handisurya, A., Stix, U., Haitel, A., Knerer, B., Gessl, A., Lee, C., and Marberger, M. (2002) Increased expression of lymphocyte-derived cytokines in benign hyperplastic prostate tissue, identification of the producing cell types, and effect of differentially expressed cytokines on stromal cell proliferation. Prostate 52, 43-58 (Pubitemid 34553191)
15. Steiner, G. E., Newman, M. E., Paikl, D., Stix, U., Memaran-Dagda, N., Lee, C., and Marberger, M. J. (2003) Expression and function of proinflammatory interleukin IL-17 and IL-17 receptor in normal, benign hyperplastic, and malignant prostate. Prostate 56, 171-182 (Pubitemid 36918167)
16. Steiner, G. E., Stix, U., Handisurya, A., Willheim, M., Haitel, A., Reithmayr, F., Paikl, D., Ecker, R. C., Hrachowitz, K., Kramer, G., Lee, C., and Marberger, M. (2003) Cytokine expression pattern in benign prostatic hyperplasia infiltrating T cells and impact of lymphocytic infiltration on cytokine mRNA profile in prostatic tissue. Lab. Investig. 83, 1131-1146 (Pubitemid 37013048)
17. Nickel, J. C., Roehrborn, C. G., O'Leary, M. P., Bostwick, D. G., Somerville, M. C., and Rittmaster, R. S. (2007) Examination of the relationship between symptoms of prostatitis and histological inflammation. Baseline data from the REDUCE chemoprevention trial. J. Urol. 178, 896-900; discussion 900-891
18. Nickel, J. C., Roehrborn, C. G., O'Leary, M. P., Bostwick, D. G., Somerville, M. C., and Rittmaster, R. S. (2008) The relationship between prostate inflammation and lower urinary tract symptoms. Examination of baseline data from the REDUCE trial. Eur. Urol. 54, 1379-1384
19. Wu, M. H., Ma, W. L., Hsu, C. L., Chen, Y. L., Ou, J. H., Ryan, C. K., Hung, Y. C., Yeh, S., and Chang, C. (2010) Androgen receptor promotes hepatitis B virus-induced hepatocarcinogenesis through modulation of hepatitis B virus RNA transcription. Science Transl. Med. 2, 32-35
20. Wang, X. H., Zhao, F. J., Han, B. M., Jiang, Q., Wang, Y. C., Wu, J. H., Tang, Y. Q., Zhang, Y. P., and Xia, S. J. (2011) Primary stromal cells isolated from human various histological/pathological prostate have different phenotypes and tumor promotion role. Chinese Med. J. 124, 1700-1707
21. Kindblom, J., Dillner, K., Sahlin, L., Robertson, F., Ormandy, C., Törnell, J., and Wennbo, H. (2003) Prostate hyperplasia in a transgenic mouse with prostate-specific expression of prolactin. Endocrinology 144, 2269-2278 (Pubitemid 36629877)
22. Lai, K. P., Yamashita, S., Vitkus, S., Shyr, C. R., Yeh, S., and Chang, C. (2012) Suppressed prostate epithelial development with impaired branching morphogenesis in mice lacking stromal fibromuscular androgen receptor. Mol. Endocrinol. 26, 52-66
23. Gu, H., Dong, Z. X., Wang, C. B., Yuan, Y. F., and Hou, J. H. (2006) Role of bFGF and TGF-β1 in primary cultured prostatic stromal cells. Zhonghua nan ke xue = Natl. J. Androl. 12, 917-922
24. Wu, C. T., Altuwaijri, S., Ricke, W. A., Huang, S. P., Yeh, S., Zhang, C., Niu, Y., Tsai, M. Y., and Chang, C. (2007) Increased prostate cell proliferation and loss of cell differentiation in mice lacking prostate epithelial androgen receptor. Proc. Natl. Acad. Sci. U.S.A. 104, 12679-12684 (Pubitemid 47255214)
25. Sciarra, A., Di Silverio, F., Salciccia, S., Autran Gomez, A. M., Gentilucci, A., and Gentile, V. (2007) Inflammation and chronic prostatic diseases. Evidence for a link? Eur. Urol. 52, 964-972 (Pubitemid 47332058)
26. Dillner, K., Kindblom, J., Flores-Morales, A., Shao, R., Törnell, J., Norstedt, G., and Wennbo, H. (2003) Gene expression analysis of prostate hyperplasia in mice overexpressing the prolactin gene specifically in the prostate. Endocrinology 144, 4955-4966 (Pubitemid 37378410)
27. Macoska, J. A. (2011) Chemokines and BPH/LUTS. Differentiation 82, 253-260
28. Coppé, J. P., Patil, C. K., Rodier, F., Sun, Y., Muñoz, D. P., Goldstein, J., Nelson, P. S., Desprez, P. Y., and Campisi, J. (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and the p53 tumor suppressor. PLoS Biol. 6, 2853-2868
29. Lai, J. J., Lai, K. P., Chuang, K. H., Chang, P., Yu, I. C., Lin, W. J., and Chang, C. (2009) Monocyte/macrophage androgen receptor suppresses cutaneous wound healing in mice by enhancing local TNF-α expression. J. Clin. Invest. 119, 3739-3751
30. Yang, Z., Chang, Y. J., Yu, I. C., Yeh, S., Wu, C. C., Miyamoto, H., Merry, D. E., Sobue, G., Chen, L. M., Chang, S. S., and Chang, C. (2007) ASC-J9 ameliorates spinal and bulbar muscular atrophy phenotype via degradation of androgen receptor. Nat. Med. 13, 348-353 (Pubitemid 46376683)
31. Chen, S. U., Chou, C. H., Lin, C. W., Lee, H., Wu, J. C., Lu, H. F., Chen, C. D., and Yang, Y. S. (2010) Signal mechanisms of vascular endothelial growth factor and interleukin-8 in ovarian hyperstimulation syndrome. Dopamine targets their common pathways. Hum. Reprod. 25, 757-767
32. Bartsch, G., Müller, H. R., Oberholzer, M., and Rohr, H. P. (1979) Light microscopic stereological analysis of the normal human prostate and benign prostatic hyperplasia. J. Urol. 122, 487-491 (Pubitemid 10245530)
33. Shapiro, E., Hartanto, V., and Lepor, H. (1992) Quantifying the smooth muscle content of the prostate using double-immunoenzymatic staining and color assisted image analysis. J. Urol. 147, 1167-1170
34. Lin, V. K., Benaim, E. A., and McConnell, J. D. (2001) α-Blockade down-regulates myosin heavy chain gene expression in human benign prostatic hyperplasia. Urology 57, 170-175 (Pubitemid 32065851)
35. Lee, K. L., and Peehl, D. M. (2004) Molecular and cellular pathogenesis of benign prostatic hyperplasia. J. Urol. 172, 1784-1791 (Pubitemid 39363056)
36. Nickel, J. C. (2008) Inflammation and benign prostatic hyperplasia. Urol. Clin. North Am. 35, 109-115; vii
37. Sciarra, A., Mariotti, G., Salciccia, S., Autran Gomez, A., Monti, S., Toscano, V., and Di Silverio, F. (2008) Prostate growth and inflammation. J. Steroid Biochem. Mol. Biol. 108, 254-260 (Pubitemid 351179630)
38. Untergasser, G., Madersbacher, S., and Berger, P. (2005) Benign prostatic hyperplasia. Age-related tissue-remodeling. Exp. Gerontol. 40, 121-128 (Pubitemid 40343002)
39. Wang, L., Yang, J. R., Yang, L. Y., and Liu, Z. T. (2008) Chronic inflammation in benign prostatic hyperplasia. Implications for therapy. Med. Hypotheses 70, 1021-1023 (Pubitemid 351400693)
40. Macoska, J. A., Begley, L. A., Dunn, R. L., Siddiqui, J., Wei, J. T., and Sarma, A. V. (2008) Pilot and feasibility study of serum chemokines as markers to distinguish prostatic disease in men with low total serum PSA. Prostate 68, 442-452 (Pubitemid 351342649)
41. Penna, G., Mondaini, N., Amuchastegui, S., Degli Innocenti, S., Carini, M., Giubilei, G., Fibbi, B., Colli, E., Maggi, M., and Adorini, L. (2007) Seminal plasma cytokines and chemokines in prostate inflammation: interleukin 8 as a predictive biomarker in chronic prostatitis/chronic pelvic pain syndrome and benign prostatic hyperplasia. Eur. Urol. 51, 524-533; discussion 533
42. Schauer, I. G., Ressler, S. J., Tuxhorn, J. A., Dang, T. D., and Rowley, D. R. (2008) Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia. Urology 72, 205-213
43. Begley, L. A., Kasina, S., MacDonald, J., and Macoska, J. A. (2008) The inflammatory microenvironment of the aging prostate facilitates cellular proliferation and hypertrophy. Cytokine 43, 194-199
44. Begley, L. A., MacDonald, J. W., Day, M. L., and Macoska, J. A. (2007) CXCL12 activates a robust transcriptional response in human prostate epithelial cells. J. Biol. Chem. 282, 26767-26774 (Pubitemid 47501894)
45. Bianchi-Frias, D., Vakar-Lopez, F., Coleman, I. M., Plymate, S. R., Reed, M. J., and Nelson, P. S. (2010) The effects of aging on the molecular and cellular composition of the prostate microenvironment. PloS One 5, e12501
46. Nicholson, T. M., and Ricke, W. A. (2011) Androgens and estrogens in benign prostatic hyperplasia. Past, present, and future. Differentiation 82, 184-199
47. Reddy, S. M., Hsiao, K. H., Abernethy, V. E., Fan, H., Longacre, A., Lieberthal, W., Rauch, J., Koh, J. S., and Levine, J. S. (2002) Phagocytosis of apoptotic cells by macrophages induces novel signaling events leading to cytokine-independent survival and inhibition of proliferation: activation of Akt and inhibition of extracellular signal-regulated kinases 1 and 2. J. Immunol. 169, 702-713 (Pubitemid 34753425)
48. Davies, J. Q., and Gordon, S. (2005) Isolation and culture of human macrophages. Methods Mol. Biol. 290, 91-103